| Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi‐site trial YI Hser, AJ Saxon, D Huang, A Hasson, C Thomas, M Hillhouse, ... Addiction 109 (1), 79-87, 2014 | 472 | 2014 |
| Implications of chronic methamphetamine use: a literature review CW Meredith, C Jaffe, K Ang-Lee, AJ Saxon Harvard review of psychiatry 13 (3), 141-154, 2005 | 438 | 2005 |
| Prevalence, comorbidity, and prognosis of mental health among US veterans RB Trivedi, EP Post, H Sun, A Pomerantz, AJ Saxon, JD Piette, ... American journal of public health 105 (12), 2564-2569, 2015 | 418 | 2015 |
| Post-traumatic stress disorder and smoking: a systematic review SS Fu, M McFall, AJ Saxon, JC Beckham, TP Carmody, DG Baker, ... Nicotine & tobacco research 9 (11), 1071-1084, 2007 | 296 | 2007 |
| Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial M McFall, AJ Saxon, CA Malte, B Chow, S Bailey, DG Baker, JC Beckham, ... Jama 304 (22), 2485-2493, 2010 | 258 | 2010 |
| Long‐term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi‐site trial YI Hser, E Evans, D Huang, R Weiss, A Saxon, KM Carroll, G Woody, ... Addiction 111 (4), 695-705, 2016 | 208 | 2016 |
| Factors affecting willingness to provide buprenorphine treatment J Netherland, M Botsko, JE Egan, AJ Saxon, CO Cunningham, ... Journal of substance abuse treatment 36 (3), 244-251, 2009 | 196 | 2009 |
| High mortality among patients with opioid use disorder in a large healthcare system YI Hser, LJ Mooney, AJ Saxon, K Miotto, DS Bell, Y Zhu, D Liang, ... Journal of addiction medicine 11 (4), 315-319, 2017 | 191 | 2017 |
| Chronic pain among patients with opioid use disorder: results from electronic health records data YI Hser, LJ Mooney, AJ Saxon, K Miotto, DS Bell, D Huang Journal of substance abuse treatment 77, 26-30, 2017 | 190 | 2017 |
| Trauma, symptoms of posttraumatic stress disorder, and associated problems among incarcerated veterans AJ Saxon, TM Davis, KL Sloan, KM McKnight, ME McFall, DR Kivlahan Psychiatric Services 52 (7), 959-964, 2001 | 189 | 2001 |
| Pre‐treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome AJ Saxon, EA Wells, C Fleming, TR Jackson, DA Calsyn Addiction 91 (8), 1197-1210, 1996 | 185 | 1996 |
| Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users. DA Calsyn, AJ Saxon, G Freeman Jr, S Whittaker American Journal of Public Health 82 (4), 573-575, 1992 | 184 | 1992 |
| A pilot trial of the alpha‐1 adrenergic antagonist, prazosin, for alcohol dependence TL Simpson, AJ Saxon, CW Meredith, CA Malte, B McBride, LC Ferguson, ... Alcoholism: Clinical and Experimental Research 33 (2), 255-263, 2009 | 179 | 2009 |
| Divalproex sodium in alcohol withdrawal: a randomized double‐blind placebo‐controlled clinical trial JP Reoux, AJ Saxon, CA Malte, JS Baer, KL Sloan Alcoholism: Clinical and experimental research 25 (9), 1324-1329, 2001 | 179 | 2001 |
| Improving the rates of quitting smoking for veterans with posttraumatic stress disorder M McFall, AJ Saxon, CE Thompson, D Yoshimoto, C Malte, ... American Journal of Psychiatry 162 (7), 1311-1319, 2005 | 150 | 2005 |
| Buprenorphine tapering schedule and illicit opioid use W Ling, M Hillhouse, C Domier, G Doraimani, J Hunter, C Thomas, ... Addiction 104 (2), 256-265, 2009 | 148 | 2009 |
| Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement … JS Potter, EN Marino, MP Hillhouse, S Nielsen, K Wiest, CP Canamar, ... Journal of Studies on Alcohol and Drugs 74 (4), 605-613, 2013 | 131 | 2013 |
| Buprenorphine/naloxone and methadone effects on laboratory indices of liver health: a randomized trial AJ Saxon, W Ling, M Hillhouse, C Thomas, A Hasson, A Ang, ... Drug and alcohol dependence 128 (1-2), 71-76, 2013 | 125 | 2013 |
| The association of persistent pain with out‐patient addiction treatment outcomes and service utilization RM Caldeiro, CA Malte, DA Calsyn, JS Baer, P Nichol, DR Kivlahan, ... Addiction 103 (12), 1996-2005, 2008 | 113 | 2008 |
| HIV risk reduction with buprenorphine–naloxone or methadone: Findings from a randomized trial GE Woody, D Bruce, PT Korthuis, S Chhatre, S Poole, M Hillhouse, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 66 (3), 288-293, 2014 | 105 | 2014 |
